The Multiple Sclerosis Society of Canada is pleased to announce a research funding opportunity aimed at improving treatment and prognosis of people living with multiple sclerosis using artificial intelligence (AI).
Through this call for proposals, we are seeking transformative ideas that leverage existing data sets of clinical and patient data and the power of artificial intelligence (AI) methodologies and approaches to support the development of a clinical decision support tool capable of optimizing and informing treatment plans for those living with MS.
Clinical decision-support tools powered by artificial intelligence have the potential to learn and benefit from the wealth of existing data on treatment responses to various disease-modifying therapies and then predict an appropriate treatment path. With the wealth of available health data, from clinical trials, patient registries, and administrative health databases for example, combined with the progress made in data analytics and advances in computational capabilities, there is opportunity to derive meaningful insights from vast amounts of data to inform clinical practice and improve the health outcomes for those living with MS.
This request for applications will support research that uses existing data sets and applies AI to develop an algorithm capable of predicting the best treatment options for people living with MS. This algorithm will serve as proof of concept for the development of a clinical decision support tool. As part of the project, the algorithm must be piloted in a real-world setting and/or with real-world data.
The AI & MS Discovery Grant is generously supported by TD Bank Group through The Ready Commitment.
Amount and Term
Applicants can request up to a maximum of $1,000,000 for a term of up to three years.
Each Project must have a Lead Principal Investigator (PI) who will oversee operations of the grant and the activities of the collaborative members. The Lead PI must hold an M.D., Ph.D., or equivalent degree, have an academic or research appointment, and be conducting research in a recognized Canadian institution. The Lead PI will assume scientific and operational oversight for the study and ensure a collaborative effort. The Lead PI should be established, highly qualified scientists with adequate administrative and leadership experience and authority to manage grant operations.
- Application opens: November 27, 2019
- FAQ teleconference: January 8, 2020 at 15:00-16:00 ET (by registration only). Register by emailing firstname.lastname@example.org
- Application Deadline: February 27, 2020 at 16:00 EDT
- Anticipated Notice of Decision: October 2020
Policies and Procedures
For more information about the Grant, please visit the links below: